Drugs / SEP-479
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07433179 | Mar 2026 → Feb 2027 expected | — | Septerna, Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SEP-479 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07433179 ↗ |
| Route | Oral | “Oral, capsule” NCT07433179 ↗ |